| Autor: |
Zharov EI, Makeeva LG, Svetova SD, Makarovskiĭ VV, Shafranskiĭ IuA, Vertkina NV |
| Jazyk: |
ruština |
| Zdroj: |
Sovetskaia meditsina [Sov Med] 1991 (12), pp. 10-3. |
| Abstrakt: |
When treated by verapamil, coronary patients responded differently. Hepatic effects can be either protective or toxic depending on the drug dosage and course duration. Verapamil hepatic protection manifests in day dosage 360 mg and the course duration 3 weeks. 600 mg verapamil is toxic irrespective of the course duration. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
